Since its founding in 1945, Daewoong Pharmaceutical has grown into a leading pharmaceutical company in South Korea through endless challenges and innovations based on the management philosophy of making good medicines to protect the health of the people and create a healthy society.
Daewoong Pharmaceutical has established itself as a representative pharmaceutical company in Korea that researches, develops, and produces pharmaceuticals with global competitiveness, including extensive partnerships with leading global healthcare companies, as well as establishing the most local infrastructure among Korean pharmaceutical companies.
In particular, Daewoong has obtained international standard certifications such as environmental management system (ISO 14001), safety and health management system (ISO 45001, KOSHA-MS), and quality management system (ISO 9001), as well as the US Food and Drug Administration (FDA), and the European Medicines Agency (EMA). ), etc., by completing the quality standard (GMP) certification of regulatory agencies in advanced countries, and is proving an advanced quality management system.
Based on continuous R&D investment and open collaboration, various new drug pipelines, and platforms aiming to become the world's first innovative new drug (FIRST-IN-CLASS) and the best innovative new drug (BEST-IN-CLASS) in the affiliated company. By striving to develop technology, we are constantly striving to improve human health and quality of life.
In the future, Daewoong Pharmaceutical will go beyond Korea's leading pharmaceutical company to become a global healthcare company. We will continue to promote new future growth by reinforcing internal integrity through responsible management and agile and flexible responses to changes in the external environment. Daewoong Pharmaceutical will strive to become a global healthcare company that creates new values for the improvement of human health and quality of life based on continuous management innovation.